Hepatitis C infection and other drug-related harms among inpatients who injected drugs in Turkey

Basit Öğe Kaydı
dc.authoridNalbandyan, Marine/0000-0003-0604-5333
dc.authoridTracy, Melissa/0000-0003-3209-0197
dc.authoridMutlu, Elif/0000-0003-0622-9327
dc.contributor.authorAlaei, A.
dc.contributor.authorAlaei, K.
dc.contributor.authorWaye, K.
dc.contributor.authorTracy, M.
dc.contributor.authorNalbandyan, M.
dc.contributor.authorMutlu, E.
dc.contributor.authorCetin, M. K.
dc.date.accessioned2024-09-11T19:52:01Z
dc.date.available2024-09-11T19:52:01Z
dc.date.issued2017
dc.departmentİstanbul Gelişim Üniversitesien_US
dc.description.abstractHepatitis C virus (HCV) is easily spread among those who share drug injection equipment. Due to the ease of contraction and growing prevalence of HCV in Eastern Europe, the aims of this study focused on describing risky injection practices as well as the prevalence of HCV, HIV and hepatitis B virus (HBV) among people who inject drugs (PWID) who were admitted to public and private drug treatment centres in Turkey from 2012 to 2013. Other aims included identifying correlates of needle sharing and HCV infection. Of the 4694 inpatients who ever injected drugs and the 3914 who injected in the past 30 days, nearly all (98%) reported heroin as their drug of choice, the vast majority reported ever sharing a needle (73.4% and 79.3%), and the mean age at first injection was 23 years. Of current PWID, 51.9% were HCV-positive, 5.9% were HBV-positive and only 0.34% of lifetime PWID were HIV-positive. Predictors of increased needle sharing include younger age, being unemployed, having lesser education and reporting heroin as a drug of choice. Significant predictors of HCV infection included being 40 years or older, receiving treatment in the Mediterranean region of Turkey, reporting heroin as a primary substance, a longer duration of drug use and sharing needles. With this information, it is essential to improve access to clean injection equipment in Turkey, to focus on improving education on clean injection practices and to enhance efforts in testing and treating HCV-positive PWID.en_US
dc.identifier.doi10.1111/jvh.12662
dc.identifier.endpage505en_US
dc.identifier.issn1352-0504
dc.identifier.issn1365-2893
dc.identifier.issue6en_US
dc.identifier.pmid27925346en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage496en_US
dc.identifier.urihttps://doi.org/10.1111/jvh.12662
dc.identifier.urihttps://hdl.handle.net/11363/7889
dc.identifier.volume24en_US
dc.identifier.wosWOS:000404519400007en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofJournal of Viral Hepatitisen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmz20240903_Gen_US
dc.subjecthepatitis C virusen_US
dc.subjectinjection drug useen_US
dc.subjectneedle sharingen_US
dc.subjectTurkeyen_US
dc.titleHepatitis C infection and other drug-related harms among inpatients who injected drugs in Turkeyen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Makale / Article
Boyut:
367.22 KB
Biçim:
Adobe Portable Document Format
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu